Nourianz Will Be a New Add-On for Parkinson's

Nourianz (NUR-ee-anz, istradefylline) will be a new add-on med for Parkinson's disease.

It's for "off" episodes...when scheduled carbidopa/levodopa wears off between doses and symptoms (tremor, rigidity, etc) return.

But Nourianz doesn't seem to reduce "off" time more than other add-ons...such as entacapone, pramipexole, or rasagiline.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals